133 related articles for article (PubMed ID: 32673437)
1. Prognostic Value of the Lymphocyte-to-Monocyte Ratio in Patients with Parotid Gland Carcinoma.
Mikoshiba T; Ozawa H; Watanabe Y; Sekimizu M; Saito S; Yoshihama K; Nakamura S; Imanishi Y; Kameyama K; Ogawa K
Laryngoscope; 2021 Mar; 131(3):E864-E869. PubMed ID: 32673437
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment lymphocyte-monocyte ratio as a potential prognostic factor in a cohort of patients with upper tract urothelial carcinoma.
Hutterer GC; Sobolev N; Ehrlich GC; Gutschi T; Stojakovic T; Mannweiler S; Pummer K; Zigeuner R; Pichler M; Dalpiaz O
J Clin Pathol; 2015 May; 68(5):351-5. PubMed ID: 25661796
[TBL] [Abstract][Full Text] [Related]
3. Prediction of outcome by lymph node ratio in patients with parotid gland cancer.
Meyer MF; Kreppel M; Meinrath J; Grünewald I; Stenner M; Drebber U; Quaas A; Odenthal M; Semrau R; Huebbers CU; Zöller J; Huettenbrink KB; Buettner R; Beutner D
Clin Otolaryngol; 2017 Feb; 42(1):98-103. PubMed ID: 27185037
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.
Lin ZX; Ruan DY; Li Y; Wu DH; Ma XK; Chen J; Chen ZH; Li X; Wang TT; Lin Q; Wen JY; Wu XY
World J Gastroenterol; 2015 Oct; 21(38):10898-906. PubMed ID: 26478681
[TBL] [Abstract][Full Text] [Related]
5. Survival in patients with parotid gland carcinoma - Results of a multi-center study.
Honda K; Tanaka S; Shinohara S; Asato R; Tamaki H; Maetani T; Tateya I; Kitamura M; Takebayashi S; Ichimaru K; Kitani Y; Kumabe Y; Kojima T; Ushiro K; Mizuta M; Yamada K; Omori K
Am J Otolaryngol; 2018; 39(1):65-70. PubMed ID: 29089142
[TBL] [Abstract][Full Text] [Related]
6. Pretherapeutic Predictive Factors for Histological High-Grade Parotid Gland Carcinoma.
Mikoshiba T; Ozawa H; Watanabe Y; Kawaida M; Sekimizu M; Saito S; Yoshihama K; Nakamura S; Nagai R; Imanishi Y; Kameyama K; Ogawa K
Laryngoscope; 2022 Jan; 132(1):96-102. PubMed ID: 34245171
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte to monocyte ratio and prognostic nutritional index predict survival outcomes of hepatitis B virus-associated hepatocellular carcinoma patients after curative hepatectomy.
Wu SJ; Lin YX; Ye H; Li FY; Xiong XZ; Cheng NS
J Surg Oncol; 2016 Aug; 114(2):202-10. PubMed ID: 27199001
[TBL] [Abstract][Full Text] [Related]
8. Preoperative Low Lymphocyte-to-Monocyte Ratio Predicts Poor Clinical Outcomes for Patients with Urothelial Carcinoma of the Upper Urinary Tract.
Zhang XK; Yang P; Zhang ZL; Hu WM; Cao Y
Urol J; 2018 Nov; 15(6):348-354. PubMed ID: 30033515
[TBL] [Abstract][Full Text] [Related]
9. Parotid gland carcinoma: 1987 and 1997 UICC T classifications compared for prognostic accuracy at 5 years.
Carinci F; Farina A; Pelucchi S; Calearo C; Fini-Storchi O; Merlo R; Pastore A
Eur Arch Otorhinolaryngol; 2001 Mar; 258(3):150-4. PubMed ID: 11374257
[TBL] [Abstract][Full Text] [Related]
10. Carcinoma of the parotid gland: developing prognostic indices.
Lequerica-Fernández P; Peña I; Villalaín L; Rosado P; de Vicente JC
Int J Oral Maxillofac Surg; 2011 Aug; 40(8):821-8. PubMed ID: 21612890
[TBL] [Abstract][Full Text] [Related]
11. The development of a prognostic score for patients with parotid carcinoma.
Vander Poorten VL; Balm AJ; Hilgers FJ; Tan IB; Loftus-Coll BM; Keus RB; van Leeuwen FE; Hart AA
Cancer; 1999 May; 85(9):2057-67. PubMed ID: 10223248
[TBL] [Abstract][Full Text] [Related]
12. Low Pretreatment Lymphocyte-Monocyte Ratio and High Platelet-Lymphocyte Ratio Indicate Poor Cancer Outcome in Early Tongue Cancer.
Ong HS; Gokavarapu S; Wang LZ; Tian Z; Zhang CP
J Oral Maxillofac Surg; 2017 Aug; 75(8):1762-1774. PubMed ID: 28063763
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Factors Associated With Decreased Survival in Patients With Acinic Cell Carcinoma of the Parotid Gland.
Liu Y; Su M; Yang Y; Zhao B; Qin L; Han Z
J Oral Maxillofac Surg; 2017 Feb; 75(2):416-422. PubMed ID: 27474461
[TBL] [Abstract][Full Text] [Related]
14. Are all prognostic factors in parotid gland carcinoma well recognized?
Stodulski D; Mikaszewski B; Stankiewicz C
Eur Arch Otorhinolaryngol; 2012 Mar; 269(3):1019-25. PubMed ID: 21822857
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in major salivary gland cancer.
Hocwald E; Korkmaz H; Yoo GH; Adsay V; Shibuya TY; Abrams J; Jacobs JR
Laryngoscope; 2001 Aug; 111(8):1434-9. PubMed ID: 11568581
[TBL] [Abstract][Full Text] [Related]
16. Perineural Invasion in Parotid Gland Malignancies.
Huyett P; Duvvuri U; Ferris RL; Johnson JT; Schaitkin BM; Kim S
Otolaryngol Head Neck Surg; 2018 Jun; 158(6):1035-1041. PubMed ID: 29337642
[TBL] [Abstract][Full Text] [Related]
17. Oncological outcome and prognostic factors in malignant parotid tumours.
Mercante G; Marchese C; Giannarelli D; Pellini R; Cristalli G; Manciocco V; Ruscito P; Pichi B; Marchesi P; Spriano G
J Craniomaxillofac Surg; 2014 Jan; 42(1):59-65. PubMed ID: 23541937
[TBL] [Abstract][Full Text] [Related]
18. Mucoepidermoid carcinoma of the parotid gland: A National Cancer Database study.
Rajasekaran K; Stubbs V; Chen J; Yalamanchi P; Cannady S; Brant J; Newman J
Am J Otolaryngol; 2018; 39(3):321-326. PubMed ID: 29559174
[TBL] [Abstract][Full Text] [Related]
19. The Preoperative Lymphocyte-to-Monocyte Ratio is Prognostic of Clinical Outcomes for Patients with Liver-Only Colorectal Metastases in the Neoadjuvant Setting.
Neofytou K; Smyth EC; Giakoustidis A; Khan AZ; Williams R; Cunningham D; Mudan S
Ann Surg Oncol; 2015 Dec; 22(13):4353-62. PubMed ID: 25773876
[TBL] [Abstract][Full Text] [Related]
20. Outcomes and prognostic factors for surgery followed by modern radiation therapy in parotid gland carcinomas.
Huang BS; Chen WY; Hsieh CE; Lin CY; Lee LY; Fang KH; Tsang NM; Kang CJ; Wang HM; Chang JT
Jpn J Clin Oncol; 2016 Sep; 46(9):832-8. PubMed ID: 27317738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
